Dartmouth College-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Dartmouth College - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013928
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dartmouth College (Dartmouth) is an academic and research institute that offers undergraduate and graduate educational programs. The institute offers programs in the fields of arts, sciences, business administration, medicine, and engineering. It operates through various faculties such as thayer school of engineering, arts and sciences, geisel school of medicine, and tuck school of business, among others. Dartmouth’s Thayer School of Engineering comprises both the undergraduate department of engineering sciences and a professional school that provides doctorate degree. The institute offers clinical and basic science departments, and MD degree, along with graduate education in the biomedical sciences and public health. It operates through its research centers and institutes located in Hanover, the US. Dartmouth is headquartered in Hanover, New Hampshire, the US.

Dartmouth College – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dartmouth College, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Dartmouth College, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Dartmouth College, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Dartmouth College, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Dartmouth College, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Dartmouth College, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
OnCyte Amends Licensing Agreement with Dartmouth College 10
ChromaDex Extends Licensing Agreement with Dartmouth College for Nicotinamide Riboside 12
ChromaDex Enters Into Licensing Agreement With Dartmouth College For Nicotinamide Riboside Technology 13
Dartmouth College – Key Competitors 14
Dartmouth College – Key Employees 15
Dartmouth College – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
Sep 25, 2017: Streamlined process opens drug development to a new class of steroids 17
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Dartmouth College, Pharmaceuticals & Healthcare, Key Facts 2
Dartmouth College, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Dartmouth College, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Dartmouth College, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Dartmouth College, Deals By Therapy Area, 2011 to YTD 2017 8
Dartmouth College, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
OnCyte Amends Licensing Agreement with Dartmouth College 10
ChromaDex Extends Licensing Agreement with Dartmouth College for Nicotinamide Riboside 12
ChromaDex Enters Into Licensing Agreement With Dartmouth College For Nicotinamide Riboside Technology 13
Dartmouth College, Key Competitors 14
Dartmouth College, Key Employees 15
Dartmouth College, Other Locations 16
Dartmouth College, Subsidiaries 16

★海外企業調査レポート[Dartmouth College-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MSCI Inc (MSCI):企業の財務・戦略的SWOT分析
    MSCI Inc (MSCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Ayala Corporation (AC)-エネルギー分野:企業M&A・提携分析
    Summary Ayala Corporation (Ayala) is a business conglomerate with diversified business groups. It operates in real estate, financial services, water, telecommunications, automotive, power generation, transport infrastructure, electronics manufacturing services, business process outsourcing, educatio …
  • Pharmerica Corp:企業の戦略的SWOT分析
    Pharmerica Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Samsung Heavy Industries Co., Ltd.:企業の戦略・SWOT・財務分析
    Samsung Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samsung Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Wabash Valley Power Association, Inc.:企業の戦略的SWOT分析
    Wabash Valley Power Association, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Panalpina World Transport (Holding) Ltd.:企業の戦略・SWOT・財務分析
    Panalpina World Transport (Holding) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Panalpina World Transport (Holding) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Senseonics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Senseonics Inc (Senseonics), a subsidiary of Senseonics Holdings Inc, is a medical device company that designs, develops and commercializes of glucose monitoring products. Its products, Eversense and Eversense XL, are implantable continuous glucose monitoring (CGM) systems that help people w …
  • Red Electrica de Espana SA (REE)-エネルギー分野:企業M&A・提携分析
    Summary Red Electrica de Espana, S.A. (REE), a subsidiary of Red Electrica Corporacion S A. is a power transmission company. The company is involved in electricity transmission and other related operations through its transmission network. It manages the high-voltage transmission grid and is also re …
  • Kmart Corporation:企業の戦略的SWOT分析
    Kmart Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development:製薬・医療:M&Aディール及び事業提携情報
    Summary Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a subsidiary of National Institutes of Health, is a research institute that conducts and supports laboratory research, clinical trials, and epidemiological studies. The institute conducts research in the …
  • Genfit SA (GNFT):企業の財務・戦略的SWOT分析
    Summary Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, NASH, TGFTX1 and Nitazoxanide (NTZ). Its TGFTX1 is a research p …
  • OSE Immunotherapeutics (OSE):製薬・医療:M&Aディール及び事業提携情報
    Summary OSE Immunotherapeutics (OSE), formerly OSE Pharma SA is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers. The company’s memopi technology is employed in studying the development of treatments for ovarian, colon and …
  • Universal Corporation:企業の戦略・SWOT・財務分析
    Universal Corporation - Strategy, SWOT and Corporate Finance Report Summary Universal Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Occidental Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Occidental Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Occidental Petroleum Corp (Occidental) is an oil and gas exploration and production company with integrated assets. The company is active in upstream exploration and production; midstream a …
  • Ichor Holdings Ltd (ICHR):企業の財務・戦略的SWOT分析
    Ichor Holdings Ltd (ICHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Iridex Corp (IRIX):医療機器:M&Aディール及び事業提携情報
    Summary Iridex Corp (Iridex) is a medical device company that manufactures and distributes laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. The company offers products such as lasers, laser delivery devices, glaucoma device …
  • Student Transportation Inc.:企業の戦略・SWOT・財務分析
    Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report Summary Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • SGS SA (SGSN):医療機器:M&Aディール及び事業提携情報
    Summary SGS SA (SGS) is a provider of inspection, verification, testing, certification and quality assurance services. The company also provides risk management, consultancy, sustainability solutions and training services. SGS inspects, samples, analyzes, and monitors raw materials, components and p …
  • Edesa Biotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Edesa Biotech Inc (Edesa Biotech) is clinical-stage pharmaceutical company that endeavors to develop late stage prescription drugs for dermatological and anorectal indications. It strives to develop safe and effective alternatives to steroids. The company’s product pipeline includes EB01, a …
  • Daya Materials Bhd (DAYA):企業の財務・戦略的SWOT分析
    Summary Daya Materials Bhd (DMB) is a chemical company that offers polymer compound solutions. The company provides bulk chemicals, catalysts, additives, inert support materials and deodorizing agents. Its polymer compound products include semi conductive compounds, medium-voltage XLPE compounds, lo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆